| |
St group
(n=57) |
n-St group
(n=46) |
p value
|
| Primary End-Point |
18 (31%) |
25 (54%) |
0.019 |
| In-Hospital infections |
1 (1.7%) |
3 (6.5%) |
ns |
| Bleeding |
1 (1.7%) |
2 (4%) |
ns |
| VTs |
4 (7%) |
4 (9%) |
ns |
| AF/ other SVTs |
11 (24%) |
12 (21%) |
ns |
| Inotropic support |
1 (1.7%) |
3 (6.5%) |
ns |
| MI |
0 (0%) |
0 (0%) |
ns |
| Mortality |
0 (0%) |
1 (2%) |
ns |
| In-Hospital Stay (days) |
5,6±1,8 |
7.7±3,9 |
0.001 |
VTs= Ventricular Tachyarrhythmias ; AF= atrial fibrillation ; SVT= Supra-Ventricular Tachyarrhythmias |
